Lv1
40 积分 2025-10-12 加入
Self-Adjuvanting Protein Vaccine Conjugated with a Novel Synthetic TLR4 Agonist on Virus-Like Liposome Induces Potent Immunity against SARS-CoV-2
7天前
已完结
Anti-tumor immune responses of tumor-associated macrophages via toll-like receptor 4 triggered by cationic polymers
16天前
已完结
Human Toll-Like Receptor 4 (hTLR4): Structural and functional dynamics in cancer
22天前
已完结
A mechanism for trif adaptor-biased signaling by toll-like receptor 4
22天前
已完结
The success of toll-like receptor 4 based vaccine adjuvants
22天前
已完结
Cancer vaccines and the future of immunotherapy
22天前
已完结
Vaccine adjuvants: Tailoring innate recognition to send the right message
28天前
已完结
Therapeutic cancer vaccines: advancements, challenges and prospects
28天前
已完结
Linking vaccine adjuvant mechanisms of action to function
28天前
已完结
An Il12 mRNA-LNP adjuvant enhances mRNA vaccine–induced CD8 T cell responses
1个月前
已完结
皖公网安备34019202002308
